|Former Common name||Adiponectin antisense Tg|
|H-2 Haplotype||No Data|
|Strain development||Developed by Kiyomi Saito, School of Pharmaceutical Sciences, Showa University in 2005. The transgene was injected into the pronuclei of C57BL/6 fertilized eggs.|
|Strain description||Adiponectin sense transgenic mice. Although the Tg mice ordinarily show similar concentration of adiponectin proteins to WT mice, during inflammation, adiponectin level is more rapidly increased in Tg mice.|
|Colony maintenance||Carrier x Carrier [or Crossing to C57BL/6NCrSlc]|
|Promoter||CAG promoter (CMV-IE enhancer, chicken beta-actin promoter, rabbit beta-globin genomic DNA)|
|Symbol name||adiponectin, C1Q and collagen domain containing|
|Common name||No Data|
|Symbol description||No Data|
|References||Biochim Biophys Acta. 2006 Jul;1761(7):709-16. Epub 2006 May 23.
Adiponectin plays an important role in efficient energy usage under energy shortage.
|Research applications||Diabetes and Obesity Research,
Immunology and Inflammation Research,
Mouse Models for Human Disease
|Specific Term and Conditions||The following terms and conditions will be requested by the DEPOSITOR.
In publishing the research results obtained by use of the BIOLOGICAL RESOURCE, a citation of the following literature(s) designated by the DEPOSITOR is requested.
Biochim. Biophys. Acta., 1761, 709-716 (2006).
In publishing the research results to be obtained by use of the BIOLOGICAL RESOURCE, an acknowledgment to the DEPOSITOR is requested.
Prior to requesting the BIOLOGICAL RESOURCE, the RECIPIENT must obtain approval from the DEPOSITOR/DEVELOPER using the Approval Form. The RECIPIENT of BIOLOGICAL RESOURCE agrees to include the DEPOSITOR and the colleague as co-authors in first publication of the results obtained by use of the BIOLOGICAL RESOURCE. For use of the BIOLOGICAL RESOURCE by a for-profit institution, the RECIPIENT must reach agreement on terms and conditions of use of it with DEPOSITOR and must obtain a prior written consent from the DEPOSITOR. The RECIPIENT must contact the DEPOSITOR in the case of application for any patents or commercial use based on the results from the use of the BIOLOGICAL RESOURCE.
|2||Genotyping protocol <PCR>|
|Depositor||Nakano, Yasuko (Yokohama College of Pharmacy)|
|Strain Status /